Search

Your search keyword '"Penna, Gerson O."' showing total 118 results

Search Constraints

Start Over You searched for: Author "Penna, Gerson O." Remove constraint Author: "Penna, Gerson O."
118 results on '"Penna, Gerson O."'

Search Results

1. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study

3. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

5. CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

8. Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study

10. The Minha Casa Minha Vida social housing programme and leprosy in Brazil: An analysis of the 100 Million Brazilian Cohort (2010-2015)

11. Early warning system using primary healthcare data in the post-COVID-19-pandemic era: Brazil nationwide case-study

13. Human Genetic Susceptibility of Leprosy Recurrence

14. Syndromic Detection of Upper Respiratory Infections in Primary Healthcare as a Candidate for COVID-19 Early Warning in Brazil: A Retrospective Ecological Study

15. Effectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil

16. Leprosy

19. Protection conferred by vaccine plus previous infection (hybrid immunity) with vaccines of three different platforms during the Omicron variant period in Brazil

20. Additional file 1 of CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study

21. Leprosy

22. Waning of mRNA Boosters after Homologous Primary Series with BNT162b2 or ChadOx1 Against Symptomatic Infection and Severe COVID-19 in Brazil and Scotland: A Test-Negative Design Case-Control Study

23. Vaccine Effectiveness of Two-Dose BNT162b2 Over Time Against COVID-19 Symptomatic Infection and Severe Cases Among Adolescents: Test Negative Design Case Control Studies in Brazil and Scotland

24. Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

25. Estimating underreporting of leprosy in Brazil using a Bayesian approach

26. Leprosy

28. Leprosy post-exposure prophylaxis risks not adequately assessed

29. Conditional Cash Transfer Program and Leprosy Incidence: Analysis of 12.9 Million Families From the 100 Million Brazilian Cohort

30. Effectiveness of the CoronaVac Vaccine in Prevention of Symptomatic and Progression to Severe COVID-19 in Pregnant Women in Brazil

31. Contributors

32. Estimating Under Reporting of Leprosy in Brazil using a Bayesian Approach

35. Contributors

36. Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae

37. Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT

38. Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae

39. Contributors

40. Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases

42. Contributors

43. Contributors

44. Contributors

45. Contributors

48. Contributors

50. Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae

Catalog

Books, media, physical & digital resources